In terms of revenue, the global medical enzymes market was valued at $4384.22 million in 2021 and is expected to reach $7760.23 million by 2030, growing at a CAGR of 6.56% during the forecast period of 2022 to 2030.

GLOBAL MEDICAL ENZYMES MARKET FORECAST 2022-2030

Global Medical Enzymes Market by Type (Hydrolase (Hyaluronidase, Lysozymes, Other Hydrolases Enzymes), Thrombolytic (Streptokinase, Urokinase, Other Thrombolytic Enzymes), Digestive Enzyme (Lactase, L-asparaginase, Other Digestive Enzymes), Endonuclease (Benzonase, Other Endonucleases)) Market by Application ( Disease Treatment, Diagnostic Tools, Biomedical Research, Other Applications) by Geography

Request free sample

Report Summary

In terms of revenue, the global medical enzymes market was valued at $4384.22 million in 2021 and is expected to reach $7760.23 million by 2030, growing at a CAGR of 6.56% during the forecast period of 2022 to 2030.

To know more about this report, request a free sample copy

Medical enzymes can be defined as prodrugs that are used to target a particular biological irreversible or reversible reaction in order to treat a particular disease. Some examples of medical enzymes include cysteine proteinases, streptokinase, urokinase, pegadamase and others.
Medical enzymes market finds application in pharmaceutical and diagnostics industries. Its expanding usage in clinical diagnosis and also as therapeutic agents in the treatment of cancer, metabolic ailments and lysosomal diseases is expected to benefit the market’s advancement.

Medical Enzymes Market

Read our latest blog on the Medical Enzymes Market

Key growth enablers of the global medical enzymes market:

  • Increased investment in healthcare research and facilities
    • With diverse applications of enzymes in the treatment of various diseases, investment in healthcare research for proper production and consumption is on the rise. Some of them are as follows-
      • According to a report by India Brand Equity Foundation (IBEF), the healthcare market in India is expected to reach $372 billion in 2022, driven by increasing health awareness, lifestyle diseases, and access to insurance. In the Union Budget 2021-22, a sum of INR 2.23 lakh crore was allocated for health and wellbeing, as well.
      • Biden-Harris administration also announced an investment of $2.1 billion to encourage infection prevention and control activities across the United States healthcare sectors. This factor is set to improve the quality of healthcare during the pandemic as well as in the future. Such proactive investments in healthcare across the world are anticipated to boost the global medical enzymes market.
  • Widening application in medical industry
  • Growing prevalence of chronic diseases and rising aging population

Key growth restraining factors:

  • Handling and safety of enzymes
  • Strict Regulations for medical enzymes
    • Enzymes fall under the definition of chemical substances and are subject to the notifications of chemicals. Moreover, safety concerns are linked to medical enzymes because of toxic by-products occurring due to the preparation process. In addition, enzyme preparations must conform to the purity compliances and standards.
    • Medicinal products are subjected to Regulation (EEC) 2309/93 and Directive 65/65/EEC. As a result, medicinal products obtained from a biotechnological process need to be authorized.

Global Medical Enzymes Market | Top Trends

  • Advancements in enzyme engineering with techniques such as directed evolution, rational design, and semi-rational approach are driving the market. Also, the machine learning method is expected to improve enzyme evolution by lowering time and resources, thereby increasing the performance of enzymes.
  • The pharmaceutical sector is recording an increased demand, with various applications in DNA replication, liver enzymes, medical cleaning, addition to digestive enzymes, and therapeutic agents.
  • Rising health issues and growing customer awareness, especially following the COVID-19 pandemic, have resulted in an increased demand for enzymes, as well. Some medicinal enzymes were also used to treat COVID-19. For instance, scientists in Munich used short strands of RNA, called small interfering RNA (siRNA), to produce coronavirus attacking enzymes.

 

Market Segmentation – Type and Application –

Market by Type:

  • Hydrolase
    • Hyaluronidase
    • Lysozymes
    • Other Hydrolases Enzymes
  • Thrombolytic
    • Streptokinase
    • Urokinase
    • Other Thrombolytic Enzymes
  • Digestive enzyme
    • Lactase
      • The majority of the market share was captured by the lactase segment under the digestive enzyme category in 2021.
      • Digestive enzymes are formed by the gastrointestinal system or by several organs, including the mouth, stomach, small intestine, and pancreas, for the degradation of fats, proteins, and carbohydrates. They help complete the digestion process and aid the absorption of nutrients. Moreover, the use of digestive supplements also enables the treatment of certain digestive disorders.
    • L-asparaginase
      • L-asparaginase is anticipated to be the fastest-growing digestive enzyme.
      • L-asparaginase has been used as an important chemotherapeutic agent for the treatment of lymphoproliferative and lymphoma diseases.
    • Other Digestive Enzymes
  • Endonuclease
    • Benzonase
    • Other Endonucleases

Market by Application:

  • Disease Treatment
    • Disease treatment is set to be the fastest-growing as well as the dominating application over the forecast period.
    • Enzymes are used in treating various diseases such as gastrointestinal disorders used to assist drug delivery. In addition, enzymes are also used for cancer therapy.
    • Therapeutic enzymes are used in the treatment of cardiovascular diseases and coagulation disorders, cancer therapy, as well as in the treatment of non-deficiency diseases.
  • Diagnostic Tools
  • Biomedical Research
  • Other Applications

Geographical Study Based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • The Asia-Pacific is anticipated to be the fastest-growing region, with a market share of 20.15% in 2021. The region’s market growth is credited to the rising level of chronic diseases due to the poor dietary habits of the population in developing countries like India, China, and Japan.
    • Government initiatives, the rise in research and development expenditure, technological advancements, and improvements in production techniques are further expected to boost the market’s growth. For example, policies like the Healthy China 2030 Plan for the development of health and primary care, the pharmaceutical PLI scheme in India, the Universal Health Coverage Schemes, and others are expected to drive the market growth in the Asia-Pacific.
    • India is the largest provider of generic drugs across the globe. The country is also the third-largest market for APIs worldwide, according to the data by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers.
  • Rest of World: Latin America, the Middle East & Africa

Major players in the global medical enzymes market:

  • BASF
  • Sanofi
  • DuPont
  • Novozymes
  • Thermo Fisher Scientific Inc
  • DSM

Key strategies adopted by some of these companies:

  • In November 2021, Novo Nordisk Pharmatech and Novozymes signed an agreement for collaboration on specialty enzymes. It aimed to develop best-in-class enzymes for use in bio-pharma processing and regenerative medicines.
  • In September 2020, Sanofi acquired Principia Biopharma Inc, which will accelerate the advancement of medicines and the research and development of the company.
  • In March 2021, Amano Enzyme introduced a product named Umamizyme Pulse, which is a non-GMO enzyme used in plant protein products to enhance and increase flavor.

Report Synopsis:

Report ScopeDetails
Market Forecast Years2022-2030
Base Year2021
Market Historical Years2018-2021
Forecast UnitsRevenue ($ Million)
Segments AnalyzedType and Application
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

BASF, DuPont, Roche Holding, Novozymes, DSM, Sanofi, Codexis, Novus, BRAIN, Sekisui, Advanced Enzymes, Amano Enzyme, BBI Solutions, Thermo Fisher Scientific, CPC Biotech

Table of Contents

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
      • WIDENING APPLICATION IN MEDICAL INDUSTRY
      • GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
    • KEY RESTRAINTS
      • HANDLING AND SAFETY OF ENZYMES
      • STRICT REGULATIONS FOR MEDICAL ENZYMES
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
      • RESEARCH AND DEVELOPMENT
      • OPERATIONS
      • OUTBOUND LOGISTICS
    • KEY BUYING CRITERIA
      • COST
      • QUALITY
      • APPLICATION
    • REGULATORY FRAMEWORK
  2. MARKET BY TYPE
    • HYDROLASE
      • HYALURONIDASE
      • LYSOZYMES
      • OTHER HYDROLASES ENZYMES
    • THROMBOLYTIC
      • STREPTOKINASE
      • UROKINASE
      • OTHER THROMBOLYTIC ENZYMES
    • DIGESTIVE ENZYME
      • LACTASE
      • L-ASPARAGINASE
      • OTHER DIGESTIVE ENZYMES
    • ENDONUCLEASE
      • BENZONASE
      • OTHER ENDONUCLEASES
  1. MARKET BY APPLICATION
    • DISEASE TREATMENT
    • DIAGNOSTIC TOOLS
    • BIOMEDICAL RESEARCH
    • OTHER APPLICATIONS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • ADVANCED ENZYMES
      • AMANO ENZYME
      • BASF
      • BBI SOLUTIONS
      • BRAIN
      • CODEXIS
      • CPC BIOTECH
      • DSM
      • DUPONT
      • NOVOZYMES
      • NOVUS
      • ROCHE
      • SANOFI
      • SEKISUI
      • THERMO FISHER SCIENTIFIC

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – MEDICAL ENZYMES

TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES

TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: GLOBAL MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL HYDROLASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL HYDROLASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL HYALURONIDASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL HYALURONIDASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL LYSOZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL LYSOZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL OTHER HYDROLASES ENZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL OTHER HYDROLASES ENZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL THROMBOLYTIC ENZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL THROMBOLYTIC ENZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL STREPTOKINASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL STREPTOKINASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL UROKINASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL UROKINASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL OTHER THROMBOLYTIC ENZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL OTHER THROMBOLYTIC ENZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: GLOBAL DIGESTIVE ENZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: GLOBAL DIGESTIVE ENZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: GLOBAL MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30: GLOBAL MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31: GLOBAL LACTASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32: GLOBAL LACTASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33: GLOBAL L-ASPARAGINASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: GLOBAL L-ASPARAGINASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: GLOBAL OTHER DIGESTIVE ENZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36: GLOBAL OTHER DIGESTIVE ENZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37: GLOBAL ENDONUCLEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38: GLOBAL ENDONUCLEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39: GLOBAL MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40: GLOBAL MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41: GLOBAL BENZONASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42: GLOBAL BENZONASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43: GLOBAL OTHER ENDONUCLEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 44: GLOBAL OTHER ENDONUCLEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 45: GLOBAL MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46: GLOBAL MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47: GLOBAL DISEASE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48: GLOBAL DISEASE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49: GLOBAL DIAGNOSTIC TOOLS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 50: GLOBAL DIAGNOSTIC TOOLS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 51: GLOBAL BIOMEDICAL RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 52: GLOBAL BIOMEDICAL RESEARCH MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 53: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 54: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 55: GLOBAL MEDICAL ENZYMES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 56: GLOBAL MEDICAL ENZYMES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 57: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58: NORTH AMERICA MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59: LEADING PLAYERS OPERATING IN NORTH AMERICA MEDICAL ENZYMES MARKET

TABLE 60: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 61: EUROPE MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 62: LEADING PLAYERS OPERATING IN EUROPE MEDICAL ENZYMES MARKET

TABLE 63: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 64: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 65: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MEDICAL ENZYMES MARKET

TABLE 66: REST OF WORLD MEDICAL ENZYMES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 67: REST OF WORLD MEDICAL ENZYMES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 68: LEADING PLAYERS OPERATING IN REST OF WORLD MEDICAL ENZYMES MARKET

TABLE 69: LIST OF MERGERS & ACQUISITIONS

TABLE 70: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 71: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 72: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: GLOBAL MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

FIGURE 8: GLOBAL MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021

FIGURE 10: GLOBAL MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021

FIGURE 15: GLOBAL MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021

FIGURE 20: GLOBAL MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021

FIGURE 25: GLOBAL MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)

FIGURE 27: GLOBAL MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

FIGURE 28: GLOBAL MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)

FIGURE 29: GLOBAL MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)

FIGURE 30: GLOBAL MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)

FIGURE 31: GLOBAL MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

FIGURE 32: NORTH AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021& 2030 (IN %)

FIGURE 33: UNITED STATES MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: CANADA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: EUROPE MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 36: UNITED KINGDOM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: GERMANY MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: FRANCE MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: ITALY MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: BELGIUM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 41: POLAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: REST OF EUROPE MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: ASIA-PACIFIC MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 44: CHINA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: JAPAN MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: INDIA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: SOUTH KOREA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: INDONESIA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: THAILAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: VIETNAM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 51: AUSTRALIA & NEW ZEALAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 52: REST OF ASIA-PACIFIC MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 53: REST OF WORLD MEDICAL ENZYMES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 54: LATIN AMERICA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 55: MIDDLE EAST & AFRICA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)

Segmentation

  1. MARKET BY TYPE
    • HYDROLASE
      • HYALURONIDASE
      • LYSOZYMES
      • OTHER HYDROLASES ENZYMES
    • THROMBOLYTIC
      • STREPTOKINASE
      • UROKINASE
      • OTHER THROMBOLYTIC ENZYMES
    • DIGESTIVE ENZYME
      • LACTASE
      • L-ASPARAGINASE
      • OTHER DIGESTIVE ENZYMES
    • ENDONUCLEASE
      • BENZONASE
      • OTHER ENDONUCLEASES
  1. MARKET BY APPLICATION
    • DISEASE TREATMENT
    • DIAGNOSTIC TOOLS
    • BIOMEDICAL RESEARCH
    • OTHER APPLICATIONS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

Request Free Sample

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Frequently Asked Questions (FAQs):

    Which applications drive the adoption of medical enzymes?

    The key applications of medical enzymes, including disease treatment, biomedical research and diagnostic tools, and others, primarily drive the adoption of medical enzymes.

    What are digestive enzymes?

    Digestive enzymes help break down food. Moreover, they also speed up chemical reactions that turn nutrients into such substances, subsequently absorbed by the digestive tract.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type

      Get In Touch

      Inquire Before Buying

      Customization

      Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

      Request Customization

      RELATED REPORTS